PATH

•

abril 08, 2020

Coronavirus: Markets’ excessive optimism

abril 08, 2020

Coronavirus: Markets’ excessive optimism

PATH

Coronavirus: Markets’ excessive optimism

abril 08, 2020

The unprecedented stimulus provided in many regions may not be a panacea. As a public health crisis, credible efforts to contain COVID-19 are also crucial. This has some serious economic ramifications, many of which have not yet materialised and which we believe markets are not pricing in. We are wary of what we see as excessive market optimism and this is the focus of this week’s update.

US equity ETFs had outflows of $1.98bn in February, followed by substantial inflows of $23.1bn in March¹, suggesting many investors were buying the dip. We believe this is likely a temporary recovery. Whilst the risk-reward potential has improved over the long-term, we expect markets to retest previous lows in the short-term, which appears to already be happening for sectors with the weakest fundamentals such as European Banks².

Some investors are predicting a very sharp hit to growth in Q2 followed by a V-shaped recovery in Q3. Many are now assuming a ~30% hit to EPS, and an EPS recovery of ~+50% in 2021, which is even sharper than the 40% seen in 2010³. This bullish scenario assumes that when lockdown measures are lifted, business will resume as usual. We believe this is unrealistic and will lead to markets being disappointed. We have outlined some of the key factors which markets may not be fully reflecting:

Early data indicate severe recession

Global Services PMIs⁴ have plummeted. Companies have already cut dividends, buybacks, staff, unnecessary costs and capex, but this may not be enough. If bankruptcies increase, unemployment will spike, impacting consumption. Last week’s US jobless report showed an immediate impact with 6.6mn claims⁵, doubling the record 3.3mn from the week before and suggests millions in the US are likely in need of funds.

Bureaucratic hurdles

Despite the US government’s promise of support, large bureaucratic hurdles mean funds may not be received by households and businesses in time. The small business loan or “Paycheck Protection Program”⁶, is experiencing issues. It is administratively tough for the federally-insured banks issuing the loans to process the vast number of applications, including verification of eligibility. Consequently some applicants have been refused loans due to lack of a prior relationship with the bank. Moreover, these measures aim to keep businesses and households afloat for a certain period. If the state of emergency is prolonged, even more stimulus may be required and this is already being proposed in Congress.

Protracted period of isolation and border restrictions

Even once a country is in recovery from COVID-19, some isolation is still likely for the remainder of 2020. For example, Singapore was initially praised for its management of the virus, but a second wave of imported cases has led to stricter lockdown measures. When a country eventually recovers and lifts its lockdown measures, business may not resume as usual, as other countries may not have recovered and re-opened borders. Given the travel sector represents approximately 10% of global GDP, this factor alone could have a great impact.

By the time the lockdown measures are lifted, the damage to the economy may already be irrevocable. This suggests further downside and that the current market optimism is premature. We believe that a V-shaped recovery is unlikely and see a U-shaped recovery as the most optimistic case.

Our list of indicators to re-invest in risk assets

In the next several weeks the US economy will approach an inflection point, as we see whether virus-affected businesses receive stimulus approved by Congress before they go bankrupt. We continue to focus on the following factors to help determine the right time to increase exposure to risk assets globally, including equities. We still see little improvement in the status of these indicators:

1. Credible steps to contain the virus and flattening of the infection rate curve:Whilst many European countries have taken credible steps, the US is far behind. The infection rate may be slowing in Europe generally, but in the US there is a risk of outbreaks intensifying outside New York City, the current epicentre. There does not appear to be a credible, coordinated nationwide virus containment or suppression plan.

2. Extreme valuations: Current developed market valuations, while more attractive by historical standards, are not at levels that we believe generally characterise a positive turning point in market direction.

3. Extreme positioning: ETF flows indicate that equity positioning is increasing and many investors appear positive about the future market direction, driven by “fear of missing out”. However, overall fear has not yet replaced greed. We believe that at a market bottom, investor sentiment generally reflects “fear” not “greed” and equity positioning would be falling not rising.

Effective monetary and fiscal policy: The policies appear to be largely in place and it has been made clear that more fiscal stimulus may come, if required. However, the implementation, especially in the US, is encountering many bureaucratic delays and segments of the economy are not yet eligible, yet require funding. Speed is essential to prevent bankruptcies, which could trigger a downward spiral, tipping the economy into deeper recession than is already likely.

Tactical Asset Allocation Changes

Below we have provided an overview of our latest, key tactical asset allocation change:

Emerging Market Local Currency Debt: Moving from Neutral to Underweight

Emerging market economies are likely to weaken further given the triple shock of a global recession, weakness in oil prices and a pandemic. Compared with 2008, emerging market economic fundamentals such as current account balances, FX reserves and fiscal balances are in a weaker position to weather this downturn. Furthermore, the number of COVID-19 cases in emerging markets has also started to escalate. Populations in these countries tend to be heavily undertested and medical resources are constrained relative to developed markets, so are less equipped to tackle the virus or provide effective containment measures. Finally, many emerging market central banks and governments have not provided swift and effective monetary and fiscal stimulus. Consequently we expect the asset class to remain volatile with further downside risk.

¹ Bloomberg data, BI ETF.

² Based on the Euro STOXX Banks Price (EUR) Index.

³ Based on S&P 500 12-month trailing EPSg. Source: Datastream, IBES, 2 April 2020. EPSg is earnings per share growth.

⁴ Source: Datastream. March 2020 IHS Markit Services Purchasing Managers’ Index (PMI).

⁵ U.S. Department of Labor. 2 April 2020 and 26 March 2020. ”The previous high was 695,000 in October 1982.” www.dol.gov/ui/data.pdf

^⁶ This is a government-backed loan for businesses with fewer than 500 employees.

RISK CONSIDERATIONS

There is no assurance that the Strategy will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market values of securities owned by the portfolio will decline and that the value of portfolio shares may therefore be less than what you paid for them. Accordingly, you can lose money investing in this portfolio. Please be aware that this strategy may be subject to certain additional risks. There is the risk that the Adviser’s asset allocation methodology and assumptions regarding the Underlying Portfolios may be incorrect in light of actual market conditions and the Portfolio may not achieve its investment objective. Share prices also tend to be volatile and there is a significant possibility of loss. The portfolio’s investments in commodity-linked notes involve substantial risks, including risk of loss of a significant portion of their principal value. In addition to commodity risk, they may be subject to additional special risks, such as risk of loss of interest and principal, lack of secondary market and risk of greater volatility, that do not affect traditional equity and debt securities. Currency fluctuations could erase investment gains or add to investment losses. Fixed-income securities are subject to the ability of an issuer to make timely principal and interest payments (credit risk), changes in interest rates (interest-rate risk), the creditworthiness of the issuer and general market liquidity (market risk). In a rising interest-rate environment, bond prices may fall and may result in periods of volatility and increased portfolio redemptions. In a declining interest-rate environment, the portfolio may generate less income. Longer-term securities may be more sensitive to interest rate changes.Equity and foreign securities are generally more volatile than fixed income securities and are subject to currency, political, economic and market risks. Equity values fluctuate in response to activities specific to a company. Stocks of small-capitalization companies carry special risks, such as limited product lines, markets and financial resources, and greater market volatility than securities of larger, more established companies. The risks of investing in emerging market countries are greater than risks associated with investments in foreign developed markets. Exchange traded funds (ETFs) shares have many of the same risks as direct investments in common stocks or bonds and their market value will fluctuate as the value of the underlying index does. By investing in exchange traded funds ETFs and other Investment Funds, the portfolio absorbs both its own expenses and those of the ETFs and Investment Funds it invests in. Supply and demand for ETFs and Investment Funds may not be correlated to that of the underlying securities. Derivative instruments can be illiquid, may disproportionately increase losses and may have a potentially large negative impact on the portfolio’s performance. A currency forward is a hedging tool that does not involve any upfront payment. The use of leverage may increase volatility in the Portfolio. Diversification does not protect you against a loss in a particular market; however, it allows you to spread that risk across various asset classes.

Andrew Harmstone

Managing Director

Global Balanced Risk Control Team

Manfred Hui

Managing Director

Global Balanced Risk Control Team

Christian Goldsmith

Executive Director

Select Article

Right Click Edit

ARTÍCULOS RELACIONADOS

PATH

Coronavirus: More stimulus to support economy and climate policy [Audio]

30-jul-2020

Christian Goldsmith shares the GBaR team’s latest market views with a focus on the impact of coronavirus.

PATH

Coronavirus: More stimulus to support economy and climate policy

23-jul-2020

The GBaR team provides an update on its latest market views and asset allocation positioning in light of the spreading impact of the coronavirus.

PATH

Coronavirus: A Critical Juncture

03-jul-2020

The GBaR team provides an update on its latest market views and asset allocation positioning in light of the spreading impact of the coronavirus.

DISCLOSURES

The views and opinions are those of the author as of the date of publication and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all portfolio managers at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

Except as otherwise indicated, the views and opinions expressed herein are those of the portfolio management team, are based on matters as they exist as of the date of preparation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date hereof.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

The information herein is a general communications which is not impartial and has been prepared solely for information and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy.

The material contained herein has not been based on a consideration of any individual client circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Past performance is no guarantee of future results. Charts and graphs provided herein are for illustrative purposes only.

This communication is not a product of Morgan Stanley’s Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This commentary is only intended for, and will be only distributed to, persons resident in jurisdictions where distribution or availability would not be contrary to local laws or regulations.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

DISTRIBUTION

This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

EMEA: This communication has been issued by Morgan Stanley Investment Management Limited (“MSIM”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong.

U.S.

A separately managed account may not be suitable for all investors. Separate accounts managed according to the strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus, please download one at morganstanley.com/im or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds.

NOT FDIC INSURED | OFFER NO BANK GUARANTEE | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY | NOT A BANK DEPOSIT

Singapore: This publication should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”), (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This publication has not been reviewed by the Monetary Authority of Singapore.

Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accepts responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.

Taiwan: This material is provided for information purposes only and does not constitute a solicitation where such a solicitation is unlawful. The products mentioned herein this material may or may not have been registered with the Securities and Futures Bureau of the Financial Supervisory Commission in Taiwan, Republic of China (“ROC”) pursuant to relevant securities laws and regulations. Such products may only be made available in the ROC if they are (a) registered for public sale in the ROC or (b) availed on a private placement basis to specified financial institutions and other entities and individuals meeting specific criteria pursuant to the private placement provisions of the ROC Rules Governing Offshore Funds.

Korea: This material is not, and under no circumstances is to be construed as an offering of securities in Korea. No representation is being made with respect to the eligibility of any recipients of this material under the laws of Korea, including but without limitation, the Foreign Exchange Transaction Law and Regulations thereunder. The Fund’s mentioned herein this material may or may not have been registered with the Financial Services Commission of Korea under the Financial Investment Services and Capital Markets Act and may not be offered directly or indirectly, in Korea or to any resident of Korea except pursuant to applicable laws and regulations of Korea.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM’s express written consent.

All information contained herein is proprietary and is protected under copyright law.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

This document may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this document in another language, the English version shall prevail.